Aurobindo Pharma Arm Expands MSD Pact, to Set Up $150-175 Million Facility
Aurobindo Pharma’s subsidiary has announced the expansion of its strategic partnership with MSD (Merck & Co.), unveiling plans to establish a new manufacturing facility with an investment of $150-175 million. The move underscores Aurobindo’s ambition to strengthen its global footprint in pharmaceuticals, enhance production capacity, and deepen collaborations with multinational partners. The facility is expected…